Investigating the role of IL-39 in graft-versus-host disease
Pathogenic role of IL-39/IL-39R signaling in graft-versus-host disease
This study is looking at how a substance called IL-39 affects the immune response in people who have had a bone marrow transplant and are at risk for graft-versus-host disease (GVHD), with the goal of finding new ways to help manage this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-11140887 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific cytokine, IL-39, contributes to graft-versus-host disease (GVHD), a serious complication that can occur after allogeneic bone marrow transplantation. The study aims to explore the mechanisms by which IL-39 activates T-cells and influences their behavior in both animal models and human patients. By examining the relationship between IL-39 levels and GVHD development, the researchers hope to clarify its role in this condition and identify potential therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients who are undergoing or have undergone allogeneic hematopoietic cell transplantation and are at risk for developing graft-versus-host disease.
Not a fit: Patients who have not undergone allogeneic bone marrow transplantation or those with other unrelated conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that reduce the incidence and severity of graft-versus-host disease in patients undergoing bone marrow transplants.
How similar studies have performed: Previous research has shown promising results regarding the role of cytokines in graft-versus-host disease, but the specific role of IL-39 is still being explored and is considered novel.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Yu, Xue-Zhong — Medical College of Wisconsin
- Study coordinator: Yu, Xue-Zhong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.